TI
EWTX icon

Trexquant Investment’s Edgewise Therapeutics EWTX Stock Holding History

Trexquant Investment’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-22,625
Closed -$367K – 1678
2025
Q3 		$367K Buy
+22,625
New +$321K ﹤0.01% 1387
2025
Q1 		– Sell
-74,781
Closed -$2M – 1633
2024
Q4 		$2M Buy
+74,781
New +$2.38M 0.02% 864
2024
Q2 		– Sell
-126,332
Closed -$2.3M – 1608
2024
Q1 		$2.3M Buy
126,332
+70,741
+127% +$1.12M 0.05% 593
2023
Q4 		$608K Buy
+55,591
New +$390K 0.01% 1004
2023
Q1 		– Sell
-32,014
Closed -$286K – 1530
2022
Q4 		$286K Buy
32,014
+14,752
+85% +$138K 0.01% 1120
2022
Q3 		$170K Sell
17,262
-12,409
-42% -$125K 0.01% 1226
2022
Q2 		$236K Buy
29,671
+7,459
+34% +$56.4K 0.01% 1259
2022
Q1 		$215K Buy
22,212
+8,189
+58% +$105K 0.01% 1168
2021
Q4 		$214K Buy
+14,023
New +$252K 0.01% 1114

Other funds holding EWTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Trexquant Investment's EWTX Position: Q4 2025 in Review

Trexquant Investment sold out of Edgewise Therapeutics (EWTX) in Q4 2025, closing a stake of 22,625 shares — an estimated $367K sold.

Trexquant Investment first reported a position in EWTX in Q4 2021 and held it in 9 quarters. The position peaked at $2.3M in Q1 2024. 199 funds tracked by Wall St. Rank hold EWTX as of Q4 2025.

  • Trexquant Investment reported no remaining Edgewise Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Trexquant Investment sold 22,625 Edgewise Therapeutics shares in Q4 2025, an estimated $367K.
  • Trexquant Investment first reported a position in Edgewise Therapeutics in Q4 2021 and held it in 9 quarters.
  • Trexquant Investment's Edgewise Therapeutics position peaked at $2.3M in Q1 2024.
  • 199 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q4 2025.

Based on Trexquant Investment's 13F filing for Q4 2025, filed 17 Feb 2026.